Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases

Adolescents with underlying diseases are at risk of severe COVID-19. The immune response of BNT162b2 may be poor among immunocompromised adolescents. We aim to describe immunogenicity of mRNA BNT162b2 among adolescents who are immunocompromised or have chronic diseases. We recruited adolescents 12–1...

Full description

Bibliographic Details
Main Authors: Napaporn Chantasrisawad, Thanyawee Puthanakit, Auchara Tangsathapornpong, Chonnamet Techasaensiri, Wanatpreeya Phongsamart, Detchvijitr Suwanpakdee, Peera Jaruampornpan, Jiratchaya Sophonphan, Piyarat Suntarattiwong, Tawee Chotpitayasunondh
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Vaccines
Subjects:
BNT162b2
immunocompromised
SARS-CoV-2 antibody
adolescent
Online Access:https://www.mdpi.com/2076-393X/10/6/871

Internet

https://www.mdpi.com/2076-393X/10/6/871

Similar Items